UDG Healthcare plc (UDG) Stock Rating Reaffirmed by Liberum Capital

UDG Healthcare plc (LON:UDG)‘s stock had its “hold” rating reaffirmed by research analysts at Liberum Capital in a report issued on Wednesday. They presently have a GBX 884 ($11.63) price objective on the stock. Liberum Capital’s target price would suggest a potential downside of 2.00% from the stock’s previous close.

Several other equities research analysts have also issued reports on the stock. Numis Securities Ltd lowered shares of UDG Healthcare plc to a “reduce” rating and set a GBX 765 ($10.06) price target on the stock. in a report on Thursday, November 9th. N+1 Singer boosted their target price on shares of UDG Healthcare plc from GBX 770 ($10.13) to GBX 841 ($11.06) and gave the stock a “hold” rating in a report on Wednesday, November 1st. Peel Hunt boosted their target price on shares of UDG Healthcare plc from GBX 840 ($11.05) to GBX 860 ($11.31) and gave the stock an “add” rating in a report on Tuesday, October 31st. Jefferies Group LLC boosted their target price on shares of UDG Healthcare plc from GBX 830 ($10.92) to GBX 855 ($11.25) and gave the stock a “hold” rating in a report on Wednesday, October 4th. Finally, Stifel Nicolaus reissued a “hold” rating and set a GBX 775 ($10.19) target price on shares of UDG Healthcare plc in a report on Thursday, August 3rd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of GBX 825.71 ($10.86).

Shares of UDG Healthcare plc (UDG) opened at GBX 902 ($11.86) on Wednesday. UDG Healthcare plc has a 1-year low of GBX 612 ($8.05) and a 1-year high of GBX 963 ($12.67).

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.thestockobserver.com/2017/11/15/udg-healthcare-plc-udg-stock-rating-reaffirmed-by-liberum-capital.html.

About UDG Healthcare plc

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for UDG Healthcare plc (LON:UDG)

Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply